Janssen Search
Search results
Calvin W. Schmidt
Calvin Schmidt is Global Commercial Strategy Leader (GCSL) for the Cardiovascular & Metabolism (CVM) therapeutic area and the GCSL for the newly created Johnson & Johnson Innovation World Without Disease Accelerator (WWDA). CVM is maximizing the ...
Ruxandra Draghia-Akli, M.D., Ph.D.
RUXANDRA DRAGHIA-AKLI, M.D., Ph.D. GLOBAL HEAD JOHNSON & JOHNSON GLOBAL PUBLIC HEALTH R&D JANSSEN RESEARCH & DEVELOPMENT Ruxandra Draghia-Akli, M.D., Ph.D., is Global Head, Johnson & Johnson Global Public Health R&D. In this role, ...
Sarah Brennan
SARAH BRENNAN COMPANY GROUP CHAIRMAN GLOBAL COMMERCIAL STRATEGY ORGANIZATION Sarah Brennan is Company Group Chairman, Global Commercial Strategy Organization, for Johnson & Johnson Innovative Medicine. In this role, Sarah will be responsible for the ...
Our Leadership
Meet Our Leadership Team Janssen aims to change the way diseases are treated, and aggressively pursues new pathways, investigating new technologies and treatment modalities in Oncology, Immunology, Neuroscience, Infectious Diseases & Vaccines, ...
J&J and Boston University Team Up to Tackle Lung Cancer
J&J and Boston University Team Up to Tackle Lung Cancer Lung cancer is the leading cause of cancer mortality across the globe, claiming more lives than colon, breast and prostate cancers—combined. At the 2018 BIO International Convention, Johnson & ...
Tammy Guld, M.S.
Tammy Guld, M.S. GLOBAL LEAD, JCI Tammy is the Global Lead of Janssen Clinical Innovation, with more than 20 years of experience in strategic and operational delivery across clinical development, regulatory affairs, and healthcare innovation. Based in New ...
Anthony Williamson, PH.D.
As Head of Technology at the Janssen Prevention Center, Anthony Williamson has broad responsibility for acquiring and developing innovative technologies for preventing non-communicable diseases. He brings to this role an impressive track record for ...
Paul Duncan
PAUL DUNCAN SENIOR DIRECTOR EXTERNAL INNOVATION IMMUNOLOGY Paul Duncan is Senior Director, External Innovation for the Immunology Global Commercial Strategy Organization of Janssen Global Services. In this role, Paul is responsible for leading the overall ...
Equitable Access: How Janssen is Re-Imagining the Future of Clinical Trials
Equitable Access: How Janssen is Re-Imagining the Future of Clinical Trials What does “innovation” mean to you? We hear it so often in today’s world; it appears as though everyone is innovating. In fact, it would almost seem odd if a core pillar of a ...
Next-Gen Baby Box Quickfire Challenge
Next-Gen Baby Box QuickFire Challenge: Creating the “Baby Box of the Future” to Promote Child Health from the Start Central to our world without disease vision is the idea that, with rapid advances in technology and science, we are better positioned to ...